Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
1 hedge funds and large institutions have $8.53M invested in Cipher Pharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
18% more capital invested
Capital invested by funds: $7.26M → $8.53M (+$1.28M)
0% more funds holding
Funds holding: 1 → 1 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$701K |
CPHR Hedge Fund Activity: Q2 2017 in Review
1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q2 2017, worth a combined $8.53M — up 18% from $7.26M a quarter earlier.
Fund positioning in CPHR was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Grandeur Peak Global Advisors, cutting an estimated $701K.
- 1 institutional investor held Cipher Pharmaceuticals Inc. (CPHR) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $8.53M of Cipher Pharmaceuticals Inc. stock for Q2 2017, up 18% quarter-over-quarter.
- 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q2 2017 and 0 closed out.
- The largest Cipher Pharmaceuticals Inc. seller in Q2 2017 was Grandeur Peak Global Advisors, an estimated $701K sold.
Based on aggregated 13F filings for Q2 2017.